Assignee
MEREO BIOPHARMA 5 INC
US·4 granted patents·3 pending applications·5 citations·filing 2016–2024
Top patents by PatentIndex Score
7 records- 0186US11512128B2VEGF/DLL4 binding agents and uses thereofMEREO BIOPHARMA 5 INC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 0283US2023279101A1Vegf/dll4 binding agents and uses thereofMEREO BIOPHARMA 5 INC·Filed 2022·Application pending·0 cites
- 0381US11136384B2Methods for treatment of cancer comprising TIGIT-binding agentsMEREO BIOPHARMA 5 INC·Filed 2020·Granted Oct 5, 2021·1 cites·30 claims
- 0478US11339213B2Methods and compositions for treatment of cancerMEREO BIOPHARMA 5 INC·Filed 2016·Granted May 24, 2022·2 cites·36 claims
- 0577US2025179169A1Combination therapy for treatment of diseaseMEREO BIOPHARMA 5 INC·Filed 2024·Application pending·0 cites
- 0674US11230596B2Methods for treatment of cancer comprising TIGIT-binding agentsMEREO BIOPHARMA 5 INC·Filed 2017·Granted Jan 25, 2022·1 cites·13 claims
- 0767US2022340653A1Methods for treatment of cancer comprising tigit-binding agentsMEREO BIOPHARMA 5 INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEREO BIOPHARMA 5 INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →